~~<i id='390649D8CB'><strike id='390649D8CB'><tt id='390649D8CB'><pre id='390649D8CB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：comprehensive 2025-09-30 00:36:28 - browse：57184

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Three trends to watch in biotech in 2024

explore

leisure time

entertainment

hotspot

leisure time

AdobeHalfayearaftersellingitsassetsatbankruptcyauction,PearTherapeutics’mostsignificantdigitaltreatm

WSS

Hospitals owned by private equity see complications spike 25%

FDA panel to weigh safety of artificial wombs for preterm births

How to keep neuroscience’s past racism from being its future

Christmas in the PICU brings some surprising joy

Akili changes sales model for its ADHD video game treatment

Albert Bourla of Pfizer: worst biopharma CEO of 2023

entertainment

leisure time

explore

Peter Hotez and the public health issue of online harassment

Eli Lilly CEO gives to Mike Pence presidential super PAC

Medical leaders decry Supreme Court decision on affirmative action

Grad students accuse University of California of wage theft

Guidelines to prevent youth baseball injuries need more muscle

Carvykti CAR

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Patients, doctors press FTC to beef up hospital merger scrutiny

Anesthesiologist group: stop taking Ozempic before surgery

Why the quest to eradicate polio has stumbled

leisure time

In Spain, a hospital brews its own CAR

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Fed up with FDA, ALS advocates consider a take

Hospitals owned by private equity see complications spike 25%

Neurocrine congenital adrenal hyperplasia trial succeeds

'A game

leisure time

entertainment

hotspot

leisure time